Investment
Features
FeesSafety
Academy
More
Pluang+

Compare YieldMax MSTR Option Income Strategy ETF (MSTY) vs Neurocrine Biosciences Inc (NBIX) Price & Performance

YieldMax MSTR Option Income Strategy ETFTrade
Neurocrine Biosciences IncTrade

Price performance (Past 24H)

Key statistics

YieldMax MSTR Option Income Strategy ETF vs Neurocrine Biosciences Inc — how do they compare? YieldMax MSTR Option Income Strategy ETF trades at $13.55, while Neurocrine Biosciences Inc trades at $179.88 (market cap $17.40B). The key difference: Neurocrine Biosciences Inc is trading nearer its 52-week high, YieldMax MSTR Option Income Strategy ETF nearer its low. Which is the better fit depends on your goals.

MSTYNBIX
Sector
Income / Options OverlayHealth
52-Week High
$108.80$180.55
52-Week Low
$11.55$123.10
Market Cap
$17.40B
Enterprise Value
$16.49B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About YieldMax MSTR Option Income Strategy ETF

MSTY is an actively managed ETF that pursues a synthetic covered call strategy on MicroStrategy Incorporated (MSTR) stock. The fund primarily sells call options on MSTR and invests in U.S. Treasury securities and other high-quality collateral. Its goal is to generate monthly income from the option premiums. This strategy provides exposure to the volatile, Bitcoin-correlated growth potential of MSTR while seeking to deliver a high yield, though it caps the potential capital appreciation of the stock.

Read more on MSTY

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.

Read more on NBIX